The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors
Open accessAbstract
Certain types of nonpsychoactive cannabinoids can potentiate glycine receptors (GlyRs), an important target for nociceptive regulation at the spinal level. However, little is known about the potential and mechanism of glycinergic cannabinoids for chronic pain treatment. We report that systemic and intrathecal administration of cannabidiol (CBD), a major nonpsychoactive component of marijuana, and its modified derivatives significantly suppress chronic inflammatory and neuropathic pain without causing apparent analgesic tolerance in rodents. The cannabinoids significantly potentiate glycine currents in dorsal horn neurons in rat spinal cord slices. The analgesic potency of 11 structurally similar cannabinoids is positively correlated with cannabinoid potentiation of the α3 GlyRs. In contrast, the cannabinoid analgesia is neither correlated with their binding affinity for CB1 and CB2 receptors nor with their psychoactive side effects. NMR analysis reveals a direct interaction between CBD and S296 in the third transmembrane domain of purified α3 GlyR. The cannabinoid-induced analgesic effect is absent in mice lacking the α3 GlyRs. Our findings suggest that the α3 GlyRs mediate glycinergic cannabinoid-induced suppression of chronic pain. These cannabinoids may represent a novel class of therapeutic agents for the treatment of chronic pain and other diseases involving GlyR dysfunction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Scalable molecular dynamics with NAMD
Phillips, J. C., Braun, R., Wang, W., Gumbart, J., Tajkhorshid, E., Villa, E., Chipot, C., Skeel, R. D., Kalé, L., & Schulten, K. (2005) · Journal of Computational Chemistry · doi:10.1002/jcc.20289 · Cited by 16,914
NMRPipe: A multidimensional spectral processing system based on UNIX pipes
Delaglio, F., Grzesiek, S., Vuister, G., Zhu, G., Pfeifer, J., & Bax, A. (1995) · Journal of Biomolecular NMR · doi:10.1007/bf00197809 · Cited by 15,965
Note on an Approximation Treatment for Many-Electron Systems
Møller, C., & Plesset, M. S. (1934) · Physical Review · doi:10.1103/physrev.46.618 · Cited by 14,614
CHARMM: The biomolecular simulation program
Brooks, B. R., Brooks, C. L., Mackerell, A. D., Nilsson, L., Petrella, R. J., Roux, B., Won, Y., Archontis, G., Bartels, C., Boresch, S., et al. (2009) · Journal of Computational Chemistry · doi:10.1002/jcc.21287 · Cited by 8,939
Quantitative assessment of tactile allodynia in the rat paw
Chaplan, S. R., Bach, F. W., Pogrel, J. W., Chung, J. M., & Yaksh, T. L. (1994) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(94)90144-9 · Cited by 7,697
Vanommeslaeghe, K., Hatcher, E., Acharya, C., Kundu, S., Zhong, S., Shim, J., Darian, E., Guvench, O., Lopes, P., Vorobyov, I., et al. (2010) · Journal of Computational Chemistry · doi:10.1002/jcc.21367 · Cited by 7,509
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia
Hargreaves, K., Dubner, R., Brown, F., Flores, C., & Joris, J. (1988) · Pain · doi:10.1016/0304-3959(88)90026-7 · Cited by 5,135
Comparative Protein Structure Modeling Using MODELLER
Eswar, N., Webb, B., Marti‐Renom, M. A., Madhusudhan, M. S., Eramian, D., Shen, M., Pieper, U., & Sali, A. (2007) · Current Protocols in Protein Science · doi:10.1002/0471140864.ps0209s50 · Cited by 2,846
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
Efficient Analysis of Experimental Observations
Dixon, W. J. (1980) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.20.040180.002301 · Cited by 2,208
Intrathecal morphine in mice: A new technique
Hylden, J. L. K., & Wilcox, G. L. (1980) · European Journal of Pharmacology · doi:10.1016/0014-2999(80)90515-4 · Cited by 1,922
Animal models of pain: progress and challenges
Mogil, J. S. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2606 · Cited by 1,120
Role of the Immune system in chronic pain
Marchand, F., Perretti, M., & McMahon, S. B. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1700 · Cited by 1,098
Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice
Zimmer, A., Zimmer, A. M., Hohmann, A. G., Herkenham, M., & Bonner, T. I. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5780 · Cited by 1,064
Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
Izzo, A. A., Borrelli, F., Capasso, R., Di Marzo, V., & Mechoulam, R. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.07.006 · Cited by 820
Molecular Structure and Function of the Glycine Receptor Chloride Channel
Lynch, J. W. (2004) · Physiological Reviews · doi:10.1152/physrev.00042.2003 · Cited by 778
Transient receptor potential channels: targeting pain at the source
Patapoutian, A., Tate, S., & Woolf, C. J. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2757 · Cited by 646
GlyR α3: An Essential Target for Spinal PGE 2 -Mediated Inflammatory Pain Sensitization
Harvey, R. J., Depner, U. B., Wässle, H., Ahmadi, S., Heindl, C., Reinold, H., Smart, T. G., Harvey, K., Schütz, B., Abo-Salem, O. M., et al. (2004) · Science · doi:10.1126/science.1094925 · Cited by 598
Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB2 receptor
Buckley, N. E., McCoy, K. L., Mezey, É., Bonner, T., Zimmer, A., Felder, C. C., Glass, M., & Zimmer, A. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00211-9 · Cited by 544
Nurmikko, T. J., Serpell, M. G., Hoggart, B., Toomey, P. J., Morlion, B. J., & Haines, D. (2007) · Pain · doi:10.1016/j.pain.2007.08.028 · Cited by 431 · cited 2×
“It is worth mentioning that one of the common practices to deliver medical cannabis to humans is via sublingual spray, which bypasses the liver and delivers drugs directly into the blood stream (Nurmikko et al., 2007).”
BackgroundProstaglandins and cycloxygenases in the spinal cord
Vanegas, H., & Schaible, H.-G. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00063-0 · Cited by 416
Cannabinoids for treatment of chronic non‐cancer pain; a systematic review of randomized trials
Lynch, M. E., & Campbell, F. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.03970.x · Cited by 397
Costa, B., Trovato, A. E., Comelli, F., Giagnoni, G., & Colleoni, M. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.11.006 · Cited by 395
Cannabis, the mind and society: the hash realities
Murray, R. M., Morrison, P. D., Henquet, C., & Forti, M. D. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2253 · Cited by 322
Ahmadi, S., Lippross, S., Neuhuber, W. L., & Zeilhofer, H. U. (2002) · Nature Neuroscience · doi:10.1038/nn778 · Cited by 312
Huestis, M. A. (2005) · Handbook of Experimental Pharmacology · doi:10.1007/3-540-26573-2_23 · Cited by 278
The glycinergic control of spinal pain processing
Zeilhofer, H. U. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5107-2 · Cited by 200
Spinal Endocannabinoids and CB 1 Receptors Mediate C-Fiber–Induced Heterosynaptic Pain Sensitization
Pernía-Andrade, A. J., Kato, A., Witschi, R., Nyilas, R., Katona, I., Freund, T. F., Watanabe, M., Filitz, J., Koppert, W., Schüttler, J., et al. (2009) · Science · doi:10.1126/science.1171870 · Cited by 184
Chronic Pain States: Pharmacological Strategies to Restore Diminished Inhibitory Spinal Pain Control
Zeilhofer, H. U., Benke, D., & Yevenes, G. E. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134636 · Cited by 162
Cannabinoid potentiation of glycine receptors contributes to cannabis-induced analgesia
Xiong, W., Cheng, K., Cui, T., Godlewski, G., Rice, K. C., Xu, Y., & Zhang, L. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.552 · Cited by 161
Self-citationInhibition of Class II Histone Deacetylases in the Spinal Cord Attenuates Inflammatory Hyperalgesia
Bai, G., Wei, D., Zou, S., Ren, K., & Dubner, R. (2010) · Molecular Pain · doi:10.1186/1744-8069-6-51 · Cited by 161
Self-citationHejazi, N. S., Zhou, C., Öz, M., Sun, H., Ye, J. H., & Zhang, L. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.019174 · Cited by 158
Self-citationAhrens, J., Demir, R., Leuwer, M., de la Roche, J., Krampfl, K., Foadi, N., Karst, M., & Haeseler, G. (2009) · Pharmacology · doi:10.1159/000201556 · Cited by 154
Neuronal Mechanism for Neuropathic Pain
Zhuo, M. (2007) · Molecular Pain · doi:10.1186/1744-8069-3-14 · Cited by 137
Grossman, M. L., Basbaum, A. I., & Fields, H. L. (1982) · The Journal of Comparative Neurology · doi:10.1002/cne.902060103 · Cited by 133
Guan, Y., Johanek, L. M., Hartke, T. V., Shim, B., Tao, Y., Ringkamp, M., Meyer, R. A., & Raja, S. N. (2008) · Pain · doi:10.1016/j.pain.2008.01.004 · Cited by 119
Self-citationAllosteric modulation of glycine receptors
Yévenes, G. E., & Zeilhofer, H. U. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01471.x · Cited by 111
Hösl, K. M., Reinold, H., Harvey, R. J., Müller, U., Narumiya, S., & Zeilhofer, H. U. (2006) · Pain · doi:10.1016/j.pain.2006.06.011 · Cited by 106
Serotonin receptor 1A-modulated phosphorylation of glycine receptor α3 controls breathing in mice.
Manzke, T., Niebert, M., Koch, U., Caley, A., Vogelgesang, S., Hülsmann, S., Ponimaskin, E., Müller, U., Smart, T., Harvey, R., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43029 · Cited by 104
On the Pharmacological Properties of Δ9‐Tetrahydrocannabinol (THC)
Costa, B. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790146 · Cited by 96
Subunit-specific modulation of glycine receptors by cannabinoids and N-arachidonyl-glycine
Yang, Z., Aubrey, K. R., Alroy, I., Harvey, R. J., Vandenberg, R. J., & Lynch, J. W. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.07.037 · Cited by 87
Cannabinoid Analgesia as a Potential New Therapeutic Option in the Treatment of Chronic Pain
Burns, T. L., & Ineck, J. R. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1g217 · Cited by 85
Examining the roles of cannabinoids in pain and other therapeutic indications: a review
Turcotte, D., Dorze, J.-A. L., Esfahani, F., Frost, E. E., Gomori, A. J., & Namaka, M. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903413534 · Cited by 72
Molecular Sites for the Positive Allosteric Modulation of Glycine Receptors by Endocannabinoids
Yévenes, G. E., & Zeilhofer, H. U. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023886 · Cited by 70
A Common Molecular Basis for Exogenous and Endogenous Cannabinoid Potentiation of Glycine Receptors
Xiong, W., Wu, X., Lovinger, D. M., & Li, Z. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.6347-11.2012 · Cited by 68
Self-citationA Selective Role for α3 Subunit Glycine Receptors in Inflammatory Pain
Harvey, V. L., Caley, A., Müller, U. C., Harvey, R. J., & Dickenson, A. (2009) · Frontiers in Molecular Neuroscience · doi:10.3389/neuro.02.014.2009 · Cited by 57
Structure and Dynamics of the Second and Third Transmembrane Domains of Human Glycine Receptor,
Ma, D., Liu, Z., Li, L., Tang, P. S., & Xu, Y. (2005) · Biochemistry · doi:10.1021/bi050256n · Cited by 50
Self-citationZhang, G., Chen, W., Lao, L., & Marvizón, J. C. G. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.07075.x · Cited by 35
Anandamide Inhibition of 5-HT3A Receptors Varies with Receptor Density and Desensitization
Xiong, W., Hosoi, M., Koo, B., & Zhang, L. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.039149 · Cited by 34
Self-citationModulation of Glycine Receptor Function by the Synthetic Cannabinoid HU210
Demir, R., Leuwer, M., de la Roche, J., Krampfl, K., Foadi, N., Karst, M., Dengler, R., Haeseler, G., & Ahrens, J. (2009) · Pharmacology · doi:10.1159/000209291 · Cited by 31
Cheng, M. H., Liu, L. T., Saladino, A. C., et al. (2007) · The Journal of Physical Chemistry B · doi:10.1021/jp075467b · Cited by 30
The Significance of Intrathecal Catheter Location in Rats
Dobos, I., Toth, K., Kékesi, G., Joó, G., Csüllög, E., Klimscha, W., Benedek, G., & Horváth, G. (2003) · Anesthesia & Analgesia · doi:10.1097/00000539-200302000-00035 · Cited by 29
Lack of positive allosteric modulation of mutated α1S267I glycine receptors by cannabinoids
Foadi, N., Leuwer, M., Demir, R., Dengler, R., Buchholz, V., de la Roche, J., Karst, M., Haeseler, G., & Ahrens, J. (2010) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-010-0506-9 · Cited by 27
Ahrens, J., Leuwer, M., Demir, R., Krampfl, K., de la Roche, J., Foadi, N., Karst, M., & Haeseler, G. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-008-0366-8 · Cited by 15
(1998) · doi:10.1002/(sici)1096-987x(19981115)19:14<1639::aid-jcc10>3.0.co;2-b
Cited by
Molecular Targets of Cannabidiol in Neurological Disorders
Ibeas Bih, C., Chen, T., Nunn, A. V. W., Bazelot, M., Dallas, M., & Whalley, B. J. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0377-3 · Cited by 578
Ligresti, A., De Petrocellis, L., & Di Marzo, V. (2016) · Physiological Reviews · doi:10.1152/physrev.00002.2016 · Cited by 469
Molecular Targets of the Phytocannabinoids: A Complex Picture
Morales, P., Hurst, D. P., & Reggio, P. H. (2017) · Progress in the Chemistry of Organic Natural Products · doi:10.1007/978-3-319-45541-9_4 · Cited by 454
Cannabinoids and Pain: New Insights From Old Molecules
Vučković, S., Srebro, D., Vujović, K. S., Vučetić, Č., & Prostran, M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01259 · Cited by 376
Foster, E., Wildner, H., Tudeau, L., Haueter, S., Ralvenius, W. T., Jegen, M., Johannssen, H., Hösli, L., Haenraets, K., Ghanem, A., et al. (2015) · Neuron · doi:10.1016/j.neuron.2015.02.028 · Cited by 356
Metadata
- Authors
- Xiong, W., Cui, T., Cheng, K., Yang, F., Chen, S.-R., Willenbring, D., Guan, Y., Pan, H.-L., Ren, K., Xu, Y., & Zhang, L.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2012-05-14
- Volume
- 209
- Issue
- 6
- Pages
- 1121-1134
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2120380781
- Cited by
- 288
- References
- 56
- FWCI
- 7.23
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.